Both NF-κB and Nrf2 have been proposed as promising targets for infection [44,45,46], while HIF-1α and PI3K have been defined as the key proteins of the tumor microenvironment, targeting cancer immunotherapy and relapse problems [58]. The gene discussed is NFKB1; the disease is neoplasm.